Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2003 Jan;145(1):17-29.
doi: 10.1007/s00701-002-1013-7.

Transvenous embolisation of dural carotid-cavernous fistulas by multiple venous routes: a series of 27 cases

Affiliations
Clinical Trial

Transvenous embolisation of dural carotid-cavernous fistulas by multiple venous routes: a series of 27 cases

K-M Cheng et al. Acta Neurochir (Wien). 2003 Jan.

Abstract

Background: Transvenous embolisation is an effective option in the treatment of dural carotid-cavernous fistulas (DCCFs). This can be achieved via a number of venous routes.

Method: From 1997 to 2001, 27 patients with DCCFs (15 unilateral and 12 bilateral) were treated by transvenous embolisation with Guglielmi detachable coils and fibered platinum coils. The transvenous embolisation routes included inferior petrosal sinus (IPS) alone (18 patients), IPS and inter-cavernous sinus (6 patients), IPS and clival plexus (1 patient), superior ophthalmic vein (SOV) via facial vein (1 patient) and SOV via superficial temporal vein (1 patient). One patient required further transarterial embolisation with polyvinyl alcohol particles.

Findings: The follow-up period ranged from 4 to 57 months (average 26 months). Two patients had transient ophthalmoplegia and 2 patients had symptomatic recurrence of the DCCF during the follow-up. There was no permanent procedure-related morbidity. Clinical cure was achieved in 26 patients (96%) and complete angiographic obliteration was documented in 24 patients (89%).

Interpretation: DCCFs can be successfully treated by transvenous embolisation via different venous routes.

PubMed Disclaimer

MeSH terms

LinkOut - more resources